LON:DXRXKainos Group Share Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Kainos Group plc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add GBX 151.50 0.00 (0.00 %) (As of 06/5/2020 04:00 PM ET) Add Compare Share Today's Range 145.78Now: GBX 151.50▼ 157.7450-Day Range 117.50MA: GBX 140.93▼ 15452-Week Range 82Now: GBX 151.50▼ 174Volume5,495 shsAverage VolumeN/AMarket Capitalization£105.42 millionP/E Ratio252.50Dividend YieldN/ABetaN/A ProfileAdvanced ChartCompetitorsHeadlines Diaceutics Plc provides data analytics and implementation services for pharmaceutical companies worldwide. It offers diagnostic landscape services, such as patient journey, lab mapping, diagnostic regulation, turnaround time, and sample availability analysis services; diagnostic tracking services, including lab tracking, patient insights, and physician segmentation services; and diagnostic payers research, diagnostic clinical landscape, integrated mapping research, buying process research, and testers/non-testers research services. The company also provides diagnostic planning services consisting of strategic and technical planning, launch planning, diagnostic partner selection, and financial forecast services; commercialization services comprising content creation, workshops, diagnostic adboards, conference support, and proficiency testing services; and reimbursement services. The company is based in Belfast, the United Kingdom.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Kainos Group. Previous Next 2.5 Community Rank Outperform VotesKainos Group has received 4 “outperform” votes. (Add your “outperform” vote.)Underperform VotesKainos Group has received 4 “underperform” votes. (Add your “underperform” vote.)Community SentimentKainos Group has received 50.00% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Kainos Group and other stocks. Vote “Outperform” if you believe DXRX will outperform the S&P 500 over the long term. Vote “Underperform” if you believe DXRX will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldKainos Group does not currently pay a dividend.Dividend GrowthKainos Group does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Kainos Group insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Price to Earnings Ratio vs. the MarketThe P/E ratio of Kainos Group is 252.50, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.19.Price to Earnings Ratio vs. SectorThe P/E ratio of Kainos Group is 252.50, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 13.58.Price to Book Value per Share RatioKainos Group has a P/B Ratio of 5.24. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next Analyst Opinion: 0.0Community Rank: 2.5Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.50 out of 5 stars Industry, Sector and Symbol Stock Exchange LON Industry Pharmaceuticals: Other Sub-IndustryN/A SectorMedical Current SymbolLON:DXRX Previous Symbol CUSIPN/A CIKN/A Webwww.diaceutics.com PhoneN/ADebt Debt-to-Equity Ratio0.53 Current Ratio8.23 Quick Ratio8.08Price-To-Earnings Trailing P/E Ratio252.50 Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales£13.44 million Price / Sales7.84 Cash FlowGBX 16.54 per share Price / Cash Flow9.16 Book ValueGBX 28.90 per share Price / Book5.24Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net MarginsN/A Return on EquityN/A Return on AssetsN/AMiscellaneous Employees111 Outstanding Shares69,583,104Market Cap£105.42 million Next Earnings DateN/A OptionableNot Optionable LSE:DXRX Rates by TradingView Receive DXRX News and Ratings via Email Sign-up to receive the latest news and ratings for DXRX and its competitors with MarketBeat's FREE daily newsletter. Kainos Group (LON:DXRX) Frequently Asked Questions Has Kainos Group been receiving favorable news coverage? Media stories about DXRX stock have trended somewhat negative on Saturday, according to InfoTrie Sentiment. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Kainos Group earned a media sentiment score of -1.1 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the stock's share price in the near future. View the latest news aboutKainos Group. Who are some of Kainos Group's key competitors? Some companies that are related to Kainos Group include DAIICHI SANKYO/S (DSNKY), Medipharm Labs (MLCPF), ONO PHARMACEUTI/ADR (OPHLY), OTCMKTS:WDEXF (WDEXF), Otsuka (OTSKF) and PLUS Products (PLUS). View all competitors. Who are Kainos Group's key executives? Kainos Group's management team includes the following people: Mr. Peter Keeling, CEO & DirectorMr. Philip H. White, CFO, Company Sec. & DirectorMr. Damian Thornton, Chief Operating OfficerMr. Jordan Clark, Chief Technical OfficerMs. Zarina Bibi, Gen. Counsel What is Kainos Group's stock symbol? Kainos Group trades on the London Stock Exchange (LON) under the ticker symbol "DXRX." How do I buy shares of Kainos Group? Shares of DXRX and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What is Kainos Group's stock price today? One share of DXRX stock can currently be purchased for approximately GBX 151.50. How big of a company is Kainos Group? Kainos Group has a market capitalization of £105.42 million and generates £13.44 million in revenue each year. Kainos Group employs 111 workers across the globe. What is Kainos Group's official website? The official website for Kainos Group is www.diaceutics.com. This page was last updated on 6/6/2020 by MarketBeat.com Staff
